Black Soldier Fly genetics specialist Beta Bugs has announced a new strategic partnership with FreezeM Cryogenetics, the developer of the patented PauseM suspended neonate technology.
Beta Bugs’s HiPer-Fly is a selectively-bred Black Soldier Fly (BSF) strain developed through more than 45 generations of genetic improvement, with its performance having been recently proven in independent trials. FreezeM’s PauseM technology, meanwhile, is a system that provides suspended neonates, which represent a standardised biological input for BSF producers with extended shelf life and high survival rates.
The two sides said the combination of Beta Bugs’ genetics with FreezeM’s production technology would “deliver enhanced performance for commercial BSF producers”.
Together, the two companies said they aim to provide commercial insect producers across Europe with a high-performance solution which will lead to improved productivity, operational efficiency and production reliability.
Germany-based breeding population
Under an agreement signed in July, Beta Bugs and FreezeM will establish a HiPer-Fly breeding population at FreezeM’s production facility in Germany, where the company operates a dedicated BSF breeding hub together with its partner Hermetia Baruth.
The colony will form the foundation for producing HiPer-Fly-PauseM suspended neonates, enabling commercial evaluation and test marketing with selected BSF producers.
Together the companies plan to undertake a programme of controlled and commercial trials during the second half of 2026, to validate the HiPer-Fly-PauseM product under real-world production conditions. The trials will focus on evaluating biological performance throughout the commercial production cycle and demonstrating improvements in consistency, productivity and yield. Full commercialisation is set to follow in 2027.
Beta Bugs CEO Dr Alan Tinch said: “Beta Bugs has made great strides in developing superior BSF genetics, as shown by recent comparative trials. We are now delighted to be collaborating with FreezeM in bringing genetic improvements to the BSF market in a package which gives producers reliable starting for neonates and allows the HiPer-Fly to achieve its genetic potential for high yield.”
Yuval Gilad, CEO of FreezeM, added: “We are excited to partner with Beta Bugs and to combine the strengths of two complementary technologies. The synergy between Beta Bugs’ advanced HiPer-Fly genetics and FreezeM’s breeding expertise and proven PauseM platform creates a consistent, reliable and scalable pathway for delivering high-performance biological inputs to commercial producers.”
